Resonant Capital Advisors’s GE HealthCare GEHC Stock Holding History

Resonant Capital Advisors’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-3,283	Closed	-$234K	–	553
2026 Q1	$234K	Sell	3,283 -67	-2%	-$5.28K	0.01%	447
2025 Q4	$275K	Buy	3,350 +13	+0.4%	+$1.01K	0.02%	356
2025 Q3	$251K	Buy	3,337 +23	+0.7%	+$1.72K	0.01%	371
2025 Q2	$245K	Buy	3,314 +579	+21%	+$40.3K	0.02%	363
2025 Q1	$221K	Buy	+2,735	New	+$235K	0.02%	346
2024 Q4	–	Sell	-2,140	Closed	-$201K	–	356
2024 Q3	$201K	Buy	+2,140	New	+$180K	0.01%	348

Other funds holding GEHC

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Resonant Capital Advisors's GEHC Position: Q2 2026 in Review

Resonant Capital Advisors sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 3,283 shares — an estimated $234K sold.

Resonant Capital Advisors first reported a position in GEHC in Q3 2024 and held it in 6 quarters. The position peaked at $275K in Q4 2025. 653 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

Resonant Capital Advisors reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
Resonant Capital Advisors sold 3,283 GE HealthCare shares in Q2 2026, an estimated $234K.
Resonant Capital Advisors first reported a position in GE HealthCare in Q3 2024 and held it in 6 quarters.
Resonant Capital Advisors's GE HealthCare position peaked at $275K in Q4 2025.
653 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Resonant Capital Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.